About Bruce Ponder
Sir Bruce Anthony John Ponder FMedSci FAACR FRS FRCP is an English geneticist and cancer researcher. He is Emeritus Professor of Oncology at the University of Cambridge and former director of the Cancer Research UK Cambridge Institute and of the Cancer Research UK Cambridge Cancer Centre. As more variants were found, Ponder’s group adapted the gene regulatory network approach pioneered by Califano to show how their effects combined to affect cellular processes and increase cancer risk. After junior hospital posts in internal medicine (1968-73) at St Thomas’ Hospital London, Ponder was awarded a PhD Clinical Fellowship at ICRF, where he worked on chromatin organisation using polyoma virus as a model. In 1997, with the Professor of Epidemiology, Nicholas Day, Ponder founded and was co-director of the Strangeways Research Laboratory for Genetic Epidemiology, with a focus on cancer. In 2007 they published the first genome-wide association study for cancer, identifying 5 genes in which variants were linked to breast cancer risk, confirmed by replication of the result in 22 laboratories world-wide.
Biography source: Wikipedia. The profile adds birthday-specific historical context from the Celebs Birthday Today editorial database.